987392

GlaxoSmithKline LLC — FEI 1033964

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
April 21, 2016
Fiscal Year
2016
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Zebulon, NC (United States)

Citations

IDCFRDescription
202721 CFR 211.192Investigations of discrepancies, failures
241921 CFR 211.198(a)Complaint Handling Procedure